Clinical Trials

42 enrolled

Breast Neoplasms, Edema, Erythema, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03598257 2026-04-13

Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer

300 enrolled

Inflammatory Breast Neoplasms

NCT01525966 2026-03-30

Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer

67 enrolled 12 charts

Breast Neoplasms, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00003042 2026-02-20

Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer

41 enrolled 9 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT02876302 2026-02-04

Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer

23 enrolled 18 charts

Breast Neoplasms, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02411656 2026-01-23

Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy

71 enrolled 11 charts

Edema, Erythema, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02971748 2026-01-22

Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy

36 enrolled 8 charts

Inflammatory Breast Neoplasms

NCT03202316 2025-12-16

Atezolizumab, Cobimetinib, and Eribulin in Treating Patients With Chemotherapy Resistant Metastatic Inflammatory Breast Cancer

37 enrolled

Inflammatory Breast Neoplasms

NCT02623972 2025-11-25

A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer

22 enrolled 12 charts

Inflammatory Breast Neoplasms

NCT00295893 2025-09-25

Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer

121 enrolled 10 charts

Breast Neoplasms, Carcinoma, Ductal, Breast, Carcinoma, Lobular, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

NCT05795101 2025-09-19

TRUDI

Phase 2 Recruiting

63 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT03515798 2025-09-12

PELICAN

52 enrolled

Inflammatory Breast Neoplasms

NCT01730833 2025-06-03

Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer

63 enrolled 11 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT05177796 2024-10-24

Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer

Phase 2 Withdrawn

Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03872388 2024-10-02

Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy

6 enrolled 8 charts

Breast Neoplasms, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01417286 2023-04-20

Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer

69 enrolled 10 charts

Breast Neoplasms, Carcinoma, Ductal, Breast, Carcinoma, Lobular, Inflammatory Breast Neoplasms

NCT01036087 2023-03-30

Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer

47 enrolled 13 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT02658812 2023-01-25

Talimogene Laherparepvec in Treating Patients With Recurrent Breast Cancer That Cannot Be Removed by Surgery

11 enrolled 16 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT03012100 2023-01-13

Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer

280 enrolled

Unilateral Breast Neoplasms, Breast Neoplasms, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00193206 2021-11-23

Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer

123 enrolled 8 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT03184558 2021-11-09

Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With TNBC

29 enrolled 10 charts

Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00464646 2021-10-25

Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer

105 enrolled 17 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT02682693 2021-02-02

GeparX

780 enrolled

Carcinoma, Ductal, Breast, Inflammatory Breast Neoplasms

NCT02892734 2020-07-16

Ipilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast Cancer

3 enrolled 11 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00820547 2019-10-22

Beverly1

100 enrolled

Breast Neoplasms, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

NCT00513695 2019-08-07

Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer

68 enrolled 10 charts

Breast Neoplasms, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

NCT01262027 2019-07-30

TKI258 for Metastatic Inflammatory Breast Cancer Patients

22 enrolled 7 charts

Breast Neoplasms, Disease, Inflammatory Breast Neoplasms

NCT02389764 2019-07-17

Nintedanib For HER2-Negative Metastatic Inflammatory Breast Cancer (MIBC)

10 enrolled 9 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00096343 2018-12-04

Paclitaxel and Carboplatin in Treating Women Who Are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast Cancer

31 enrolled

Breast Neoplasms, Carcinoma, Ductal, Breast, Carcinoma, Lobular, Inflammatory Breast Neoplasms

NCT00499122 2018-01-02

NOV-002, Doxorubicin, Cyclophosphamide, and Docetaxel in Women With Newly Diagnosed Stage II or IIIC Breast Cancer

41 enrolled 10 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00006110 2017-07-31

NRR

82 enrolled 13 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00003199 2017-07-12

Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer

50 enrolled 11 charts

Breast Neoplasms, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

NCT00016549 2017-07-02

Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer

21 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00856492 2017-06-27

S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer

215 enrolled 13 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00182793 2017-02-23

Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer

32 enrolled 6 charts

Breast Neoplasms, Carcinoma, Ductal, Breast, Carcinoma, Lobular, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

NCT02199418 2017-01-25

SHPD001

132 enrolled

Carcinoma, Ductal, Breast, Inflammatory Breast Neoplasms

NCT00957125 2016-09-08

PROMIX

Phase 2 Unknown

151 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00105950 2015-09-28

Study Of Lapatinib In Patients With Relapsed Or Refractory Inflammatory Breast Cancer

126 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00756470 2014-11-17

Phase II Neoadjuvant in Inflammatory Breast Cancer

15 enrolled 10 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00118053 2013-11-20

Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer

5 enrolled 6 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00049114 2013-06-06

Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer

62 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00072319 2013-03-04

Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00558103 2013-02-04

Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer

163 enrolled 14 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00005798 2012-10-26

CTC

209 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00005800 2012-09-25

Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer

45 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00943410 2012-08-15

Trastuzumab and External Beam Radiation Therapy in Treating Women With Stage III or Stage IV Breast Cancer

19 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT01641406 2012-07-16

NACprotocol

Phase 2 Unknown

60 enrolled

Breast Carcinoma In Situ, Carcinoma, Lobular, Inflammatory Breast Neoplasms

NCT00343512 2012-04-27

Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer

34 enrolled 9 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00398489 2010-11-09

Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery

Phase 2 Unknown

94 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00162812 2008-07-18

TOP

338 enrolled